Indeed, we found higher levels of serum SARS-CoV-2-Spike-RBD (Receptor binding domain on Spike protein)-specific antibodies in the blood of AA and MA compared to SA patients (Figure 6I), and made similar observations on a larger cohort of 506 COVID-19 patients (28). Here, CHMP5 is linked to COVID-19.